Skip to main content

Table 5 Icodextrin use correlated with cholesterol proportions in lipoprotein fractions

From: Relationship between Icodextrin use and decreased level of small low-density lipoprotein cholesterol fractioned by high-performance gel permeation chromatography

   

Icodextrin

 

Class

Subclass

Fraction

β

p

CM

 

F1

-0.0026 (0.0027)

0.35

  

F2

-0.0011 (0.0015)

0.47

VLDL

Large VLDL

F3

-0.0033 (0.0030)

0.27

  

F4

-0.0063 (0.0055)

0.26

  

F5

-0.0077 (0.0075)

0.31

 

Medium VLDL

F6

-0.0094 (0.0071)

0.19

 

Small VLDL

F7

-0.0023 (0.0039)

0.55

LDL

Large LDL

F8

-0.00057 (0.0096)

0.95

 

Medium LDL

F9

-0.014 (0.012)

0.25

 

Small LDL

F10

-0.017 (0.0079)

0.037*

 

Very small LDL

F11

-0.0061 (0.0027)

0.026*

  

F12

-0.00083 (0.00089)

0.36

  

F13

0.00011 (0.00035)

0.76

HDL

Very large HDL

F14

0.00075 (0.00043)

0.087

  

F15

0.012 (0.0055)

0.040*

 

Large HDL

F16

0.036 (0.017)

0.047*

 

Medium HDL

F17

0.020 (0.0075)

0.009*

 

Small HDL

F18

0.0033 (0.0044)

0.45

 

Very small HDL

F19

-0.00016 (0.0015)

0.92

  

F20

0.00047 (0.00037)

0.20

  1. Values are expressed as estimated parameter (standard error) and p values. The variables in multivariate linear regression analysis include gender, body mass index, DM, total cholesterol level, statin use, and icodextrin use. *, p<0.05
  2. Abbreviations: icodextrin icodextrin use, β estimated parameter; CM chylomicron, VLDL very-low-density lipoprotein, LDL low-density lipoprotein, HDL high-density lipoprotein, cholesterol proportion, proportion of cholesterol level in each lipoprotein fraction to total cholesterol level; DM diabetes mellitus.
Back to article page

BMC Nephrology

ISSN: 1471-2369

Contact us